Company page

Bicara Therapeutics Inc.

Bicara Therapeutics Inc. is a public company traded under the ticker BCAX in the American market. The company has a market capitalization of approximately $1.43 billion. Bicara focuses on developing innovative therapies, although specific product details and financial metrics are not provided.